Cutaneous ulcers in association with sprue‐like enteropathy secondary to Losartan

Abstract

Abstract Losartan is an angiotensin II receptor blocker (ARB) which may cause severe sprue‐like enteropathy (SLE) with skin manifestation. Clinicians should be informed of this side effect and its reversibility after cessation of the drug.

Keywords

• angiotensin II receptor blocker
• chronic diarrhea
• Losartan
• sprue‐like enteropathy